Cell entry of coronaviruses involves two principal steps: receptor binding and 26 membrane fusion, the latter of which requires activation by host proteases, particularly 27 lysosomal proteases. Despite the importance of lysosomal proteases in both coronavirus 28 entry and cell metabolism, the correlation between lysosomal proteases and cell tropisms 29 of coronaviruses has not been critically established. Here we examined the roles of 30 lysosomal proteases in activating coronavirus-surface spike proteins for membrane 31 fusion, using the spike proteins from SARS and MERS coronaviruses as the model 32 system. To this end, we controlled the contributions from receptor binding and other host 33 proteases, thereby attributing coronavirus entry solely or mainly to the efficiency of 34 lysosomal proteases in activating coronavirus-spike-mediated membrane fusion. Our 35 results showed that lysosomal proteases from bat cells support coronavirus-spike-36 mediated pseudovirus entry and cell-cell fusion more effectively than their counterparts 37 from human cells. Moreover, purified lysosomal extracts from bat cells cleave cell-38 surface-expressed coronavirus spike proteins more efficiently than their counterparts 39 from human cells. Overall, our study suggests that differential lysosomal protease 40 activities from different host species and tissue cells are an important determinant of the 41 species and tissue tropism of coronaviruses. 42 43 44 45 on September 26, 2018 by guest http://jvi.asm.org/ Downloaded from Significance 46 Coronaviruses are capable of colonizing new species, as evidenced by the recent 47 emergence of SARS and MERS coronaviruses; they can also infect multiple tissues in the 48 same species. Lysosomal proteases play critical roles in coronavirus entry by cleaving 49
viral and host membranes through its S2 subunit. The membrane fusion step by 83 coronavirus spikes requires two prior cleavages by host proteases: the first at the S1/S2 84 boundary (i.e., S1/S2 site) and the second within S2 (i.e., S2' site) (8, (19) (20) (21) . Depending 85 on the virus, the spike-processing proteases may come from different stages of the 86 coronavirus infection cycle. For MERS-CoV, its spike can be processed by proprotein 87 convertases (e.g., furin) during the molecular maturation process in virus-producing cells, 88 by cell-surface proteases (e.g., transmembrane protease serine 2 or TMPRSS2) after viral 89 attachment, and by lysosomal proteases (e.g., cathepsins) after endocytosis in virus-90 targeted cells (22) (23) (24) (25) (26) . It was previously reported that MERS-CoV spike could be 91 processed by furin after viral endocytosis in virus-targeted cells (21), but this finding was 92 not supported by a recent study (27) . The protease activation pattern of SARS-CoV entry 93 is similar to that of MERS-CoV, except that SARS-CoV spike can also be processed by 94 extracellular proteases (e.g., elastase) after viral release (20, 28-30). It has been suggested 95 that the tissue tropisms of MERS-CoV and SARS-CoV are correlated with the tissue 96 distributions of proprotein convertases, extracellular proteases, and cell-surface proteases 97 in the host (22, 23, 26, (29) (30) (31) . For example, the availability of trypsin-like proteases in 98 the respiratory tracts has been suggested to be a determinant of the respiratory tropism of 99 SARS-CoV (29, 30). However, although coronavirus entry also depends on lysosomal 100 proteases, it is not clear whether the species and tissue tropism of coronaviruses are 101 correlated with differential lysosomal protease activities from different hosts or tissue 102
cells. 103
genetically highly similar to each other; some of the bat SARS-like coronaviruses 106 recognize the same receptor angiotensin-converting enzyme 2 (ACE2) as human SARS-107
CoV (32-35). MERS-like coronaviruses isolated from bats and MERS-CoV isolated from 108 humans so far are also genetically similar to each other, albeit not as similar as between 109 bat SARS-like coronaviruses and human SARS-CoV (36-39). Several MERS-like 110 coronaviruses from bats, including HKU4, recognize the same receptor dipeptidyl 111 peptidase 4 (DPP4) as MERS-CoV (24, 40-43). Moreover, human lysosomal proteases 112 only activate the MERS-CoV spike, but not the HKU4 spike, for viral entry into human 113 cells, while bat lysosomal proteases activate both MERS-CoV and HKU4 spikes for viral 114 entry into bat cells (44). Furthermore, the expression level of lysosomal proteases in 115 human lung cells is lower than in human liver cells, leading to inefficient activation of 116 MERS-CoV spike by lysosomal proteases in human lung cells (45). These results point to 117 the possibility that lysosomal protease activities differ among cells from different hosts or 118 even among cells from the same host species, restricting coronavirus entry and their 119 tropism. However, these studies did not control the contribution from host receptors, 120 despite the fact that receptor homologues from different host species may differ in their 121 functions as coronavirus receptors or that the same receptor protein may be expressed at 122 different levels in different tissues within one host species. Moreover, these studies were 123 carried out at the cellular level, and did not provide direct biochemical evidence to 124 demonstrate that lysosomal proteases from human and bat cells process coronavirus 125 spikes differentially. Therefore, factor-controlled viral entry data and direct biochemical 126 data are both needed to critically and directly establish the correlation between lysosomal 127 protease activities and coronavirus tropism. To study lysosomal-proteases-activated coronavirus entry, we must carefully 141 control for the contributions from the host receptor and other intracellular and 142 extracellular proteases, such that coronavirus-spike-mediated viral entry would be solely 143 or mainly dependent on the contribution from lysosomal proteases. In other words, we 144 partition the membrane fusion process from the receptor binding step and also separate 145 the effects of lysosomal proteases from the other proteases that may participate in 146 coronavirus entry. To this end, we screened for cell lines that met the following three 147 criteria: (i) The cells from different species or tissues endogenously must express no or 148 low levels of receptor protein for the coronavirus of interest, such that they can be 149 controlled to exogenously express the receptor protein from a single host species; (ii) The 150 cells must express no or low level of cell-surface proteases, such that lysosomal proteases 151 on September 26, 2018 by guest http://jvi.asm.org/ Downloaded from from these cells are the only or main cellular proteases that activate the membrane fusion 152 process for the coronavirus of interest (proprotein convertases are not a factor here 153 because the same batch of viruses, which had gone through the same molecular 154 maturation process, would be used to infect different cells); (iii) The cells can be 155 transfected easily, such that the cells from different origins can be controlled to express 156 similar levels of the receptor protein from a single host species. In sum, we were looking 157 for cells that are both "naked" (not expressing or expressing low levels of coronavirus 158 receptor or cell-surface proteases) and "easily transfectable". 159
To identify and exclude those cells that endogenously express coronavirus 160 receptors, we performed coronavirus-spike-mediated pseudovirus entry in a number of 161 human, monkey and bat cell lines. To this end, retroviruses pseudotyped with the MERS-162
CoV or SARS-CoV spike (i.e., MERS-CoV pseudoviruses or SARS-CoV pseudoviruses, 163 respectively) were used to test the endogenous levels of receptor expression from 164 different cell lines including human kidney cells (HEK293T), human cervix cells (HeLa), 165 human liver cells (Huh7), human lung cells (A549 and MRC5), monkey kidney cells 166 (Vero), bat kidney cells (RSKT and BKD9), and bat lung cells (PESU-B5L and Tb1-Lu). 167
The results showed that among these cells, Huh7 cells, Vero cells, MRC5 cells, PESU-168
B5L cells, and RSKT cells all supported significant levels of MERS-CoV pseudovirus 169
entry, suggesting that these cells endogenously express significant levels of DPP4 (either 170 human, monkey, or bat DPP4, depending on the cell origin) ( Fig. 1A) . In contrast, only 171
Vero cells and RSKT cells supported significant levels of SARS-CoV pseudovirus entry, 172
suggesting that these cells endogenously express significant levels of ACE2 (monkey and 173 bat ACE2, respectively) ( Fig. 1B) . These results are largely consistent with previous 174 on September 26, 2018 by guest http://jvi.asm.org/ Downloaded from studies with two exceptions: previous studies showed that PESU-B5L cells do not 175 support the infection of MERS-CoV and that Huh7 cells support the infection of SARS-176
CoV (35, 40, 44, (46) (47) (48) . Overall, the cells that endogenously express significant levels of 177 DPP4 or ACE2 were not suitable for studying the roles of lysosomal proteases in 178 coronavirus entry and hence were excluded from downstream studies. 179
To investigate which of the cells can be controlled to exogenously express 180 significant levels of coronavirus receptors, we transfected these cells with a plasmid 181 encoding human DPP4. We then performed Western blotting using an antibody 182 recognizing the C-terminal C9 tag of exogenously expressed human DPP4 in these cells 183 HEK293T, HeLa cells, and Tb1-Lu cells were selected for downstream studies designed 188 to evaluate the roles of lysosomal proteases in coronavirus entry because they met two of 189 the three aforementioned criteria: they are naked without endogenously expressing 190 coronavirus receptors, and they are easily transfectable and hence can be controlled to 191 exogenously express coronavirus receptors. In addition, an MTT cell viability assay 192 showed that the viabilities of these three types of cells were not affected by the presence 193 of different protease inhibitors, allowing the use of these protease inhibitors in 194 characterizing the roles of different proteases in coronavirus entry ( Fig. 1D ). (b-Tb1-Lu). The results showed that all three types of cells supported MERS-CoV 205 pseudovirus entry at significant levels when they exogenously expressed human DPP4 206 ( Fig. 2A ). After the expression levels of cell surface-associated human DPP4 were 207 measured and calibrated across the three types of cells ( Fig. 2A To further compare the coronavirus-spike-processing activities of human and bat 295 lysosomal proteases, we examined whether lysosomal extracts from human and bat cells 296 process the spike protein from a MERS-like bat coronavirus HKU4 differentially. 297
Previously we showed that HKU4 spike contains a glycosylated lysosomal protease site 298 at the S1/S2 boundary and it mediates virus entry into bat cells, but not human cells (44). 299
Here we investigated direct biochemical evidence for the differential HKU4-spike-300 processing activities of human and bat lysosomal proteases. To this end, we purified 301 lysosomal extracts from h-HEK293T cells and b-Tb1-Lu cells, and incubated them 302 individually with HKU4 spike expressed on the surface of h-HEK293T cells. The result 303 showed that lysosomal extrats from b-Tb1-Lu cells, but not their counterparts from h-304 HEK293T cells, cleaved HKU4 spike containing a glycosylated lysosomal protease motif 305 to produce S2 (Fig. 6A ). Next we introduced an N762A mutation into HKU4 spike; the 306 mutation had been shown to remove the glycosylation from the lysosomal protease motif The tropism of coronaviruses includes their species and tissue tropism (1). 316
Lysosomal proteases play a critical role in coronavirus entry (8, 10, 11), but their roles in 317 coronavirus tropism have not been critically established. In contrast, extracellular 318 proteases and other cellular proteases have been shown to be important determinants of 319 coronavirus tropism (22, 23, 26, 29-31). We and others previously showed that a MERS-320 like coronavirus from bats, HKU4, uses the same host receptor DPP4 as MERS-CoV (24, 321 41), and we also showed that cellular proteases from bat and human cells differentially 322 support HKU4 entry (24, 44). However, two factors can complicate the roles of 323 lysosomal proteases in coronavirus tropism: human and bat DPP4 molecules have 324 different activities as coronavirus receptors, and other proteases may also play significant 325 roles in the cell entry process of coronaviruses. In the current study, we quantified and 326 controlled the contributions from host receptor and other proteases to coronavirus entry, 327 such that the role of lysosomal proteases could be clearly defined in coronavirus entry 328 into cells from different origins. To this end, we screened a number of cell lines 329 originated from different tissues and host species and found three types of cells that were Moreover, we prepared lysosomal extracts from human and bat cells, and showed that 348 lysosomal extracts from bat cells cleaved MERS-CoV spike more efficiently than their 349 counterparts from human cells. We also showed that lysosomal extracts from bat cells 350 cleaved HKU4 spike, which contains a glycosylated lysosomal protease motif, more The correlation between lysosomal protease activities and coronavirus tropism is 356 a novel finding in virology. Previous studies already showed that the expression levels of 357 lysosomal proteases vary among different tissues within the same host species, due to the 358 different physiological functions of tissue cells (7, 45). Our study demonstrates that 359 lysosomal protease activities may also vary among different mammalian species, 360
indicating that adaptation of coronaviruses to new species may occur through adaptation 361 to different lysosomal protease activities. The physiological reason behind different 362 lysosomal protease activities among mammalian species is not clear, but it could be due 363 to different lifestyles of these species. For instance, although speculative, bats are the 364 only flying mammals and hence the enhanced lysosomal protease activities of bat cells 365 may provide fast turnover of metabolic products and also produce high levels of 366 nutrients. In this sense, supporting coronavirus entry efficiently could be a byproduct of 367 the enhanced lysosomal protease activities of bat cells. It is worth noting that due to the 368 difficulty in culturing bat tissue cells, this study was performed using bat cell lines. 369
Although cell lines usually maintain many features of original tissue cells, these findings 370 will need to be confirmed using bat tissue cells. Our study suggests that no matter 371 whether cells are from different host species or from different tissues of the same host 372 species, those cells with higher lysosomal protease activities in general support 373 coronavirus entry more efficiently than the cells with lower lysosomal proteases do. It 
Coronavirus-spike-mediated pseudovirus entry into human and bat cells 407
Retroviruses pseudotyped with MERS-CoV or SARS-CoV spike protein (i.e., 408 MERS-CoV pseudoviruses or SARS-CoV pseudoviruses, respectively) were generated as 409 described previously (24). Briefly, HEK293T cells were co-transfected with a plasmid Inhibition of pseudovirus entry using various protease inhibitors was carried out 426 as described previously (50). Briefly, target cells were preincubated with medium 427 containing a final concentration of 50 μM camostat mesylate (Sigma-Aldrich), 50 μM E-428 64d (Sigma-Aldrich), 50 μM Chloromethylketone (Enzo), or DMSO (negative control) at 429 37 °C for 1 hour. The cells were subsequently infected by pseudoviruses. The cells were 430 incubated at 37 °C for 6 to 8 hours, and then the medium was replaced with fresh 431 DMEM. After another 48 hours, the cells were lysed and measured for luciferase activity. 432
Exogenous expression of coronavirus receptor in cells and cell surfaces 433
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To examine the exogenous expression level of coronavirus receptor in whole cell 434 lysates, cells were transfected with pcDNA3.1(+) plasmid encoding human DPP4 or 435 human ACE2 containing a C-terminal C9 tag. 48 hours after transfection, the cells were 436 lysed using ultrasonication, and aliquots of cell lysates were subjected to Western 437 blotting analysis. The C9-tagged coronavirus receptors were detected using an anti-C9 438 tag monoclonal antibody (Santa Cruz Biotechnology). The current assay measures the 439 total expression level of coronavirus receptor in a certain amount of cells, without 440 specifying how many of these cells were transfected or how much protein was expressed 441 in each transfected cell. 442
To examine the exogenous expression level of coronavirus receptor in cell 443 membranes, the cells expressing the receptor were harvested as above and all membrane-444 associated proteins were extracted using the Membrane Protein Extraction Kit (Thermo 445
Fisher Scientific). Briefly, cells were centrifuged at 300 × g for 5 minutes and washed 446 with Cell Wash Solution twice. The cell pellets were resuspended in 0.75 mL 447
Permeabilization Buffer and incubated at 4°C for 10 minutes. The supernatant containing 448 cytosolic proteins was removed after centrifugation at 16,000 × g for 15 minutes. The 449 pellets containing membrane-associated proteins were resuspended in 0.5 mL 450 Solubilization Buffer and incubated at 4°C for 30 minutes. After centrifugation at 16,000 451 × g for 15 minutes, the membrane-associated proteins from the supernatant were 452 transferred to a new tube. The expression level of membrane-associated C9-tagged 453 coronavirus receptor among the membrane-associated proteins was then measured using 454
Western blot analysis as above, and further used for normalizing the results from 455 pseudovirus entry assays. Although the current assay could not differentiate between 456 on September 26, 2018 by guest http://jvi.asm.org/ Downloaded from plasma membrane-associated proteins and internal membrane-associated proteins, ACE2 457 and DPP4 are known to be strongly associated with plasma membranes due to their 458 respective plasma-membrane-targeting signal peptide (51, 52). 459
MTT assay 460
Cells were seeded in 96-well plates and treated with DMSO or DMSO-dissolved 461 protease inhibitors at 37 °C. After incubation for 6 hours, the medium was replaced with 462 fresh DMEM. After incubation for 70 hours at 37 °C, 10 μL MTT solution (Biotium) was 463 added to each well and mixed with the medium. After incubation at 37 °C for 2 hours, 464
200 μL DMSO or DMSO-dissolved protein inhibitor was added to each well and mixed 465 with the medium. The MTT signal was measured as absorbance at 570 nm using Synergy 466 2 multi-mode microplate reader (BioTek Instruments). 467
Preparation of lysosomal extracts 468
Lysosomal extracts from human or bat cells were prepared according to the 469 lysosome isolation kit procedure (Sigma-Aldrich). Briefly, cells were harvested and 470 washed by PBS buffer, and then resuspended by 2.7 PCV (i.e., packed cell volume) 471 extraction buffer. Cells were broken in a 7 ml Dounce homogenizer using a loose pestle 472 (i.e., Pestle B) until 80%-85% of cells were broken (protease inhibitors from the kit were 473 omitted in our procedure). The samples were centrifuged at 1,000xg for 10 min, and the 474 supernatants were transferred to a new centrifuge tube and centrifuged at 20,000xg for 475 another 20 min. The supernatants were removed, and then the pellets were resuspended in 476 Then fluorescence intensities at Ex/Em 360/440 nm were measured using Synergy 2 509 multi-mode microplate reader (BioTek Instruments). Calculation of the alkaline 510 phosphatase activity was performed according to the manufacturer's manual. 511
Coronavirus-spike-mediated cell-cell fusion 512
Cell-cell fusion was performed as described previously (53). Briefly, to produce 513 cells expressing one of the coronavirus spikes, HEK293T cells were co-transfected with 514 plasmid pFR-Luc, which contains a synthetic promoter with five tandem repeats of the 515 yeast GAL4 binding sites that controls expression of the luciferase gene, and 516 pcDNA3.1(+) plasmid encoding one of the coronavirus spikes. To produce cells 517 expressing one of the corresponding coronavirus receptor proteins, HEK293T cells were 518 co-transfected with pBD-NF-kappaB, which encodes a fusion protein with the DNA 519 binding domain of GAL4 and transcription activation domain of NF-kappaB, and 520 pcDNA3.1(+) plasmid encoding one of the corresponding coronavirus receptor proteins. 521
After culturing for 24 hours, the spike-expressing HEK293T cells were lifted, 522 centrifuged, and then resuspended in low pH medium containing 10 mM sodium citrate 523 pH 5.6. Subsequently the spike-expressing HEK293T cells were treated with purified 524 lysosomal extracts (100 µg/ml) in the low pH medium. After incubation at 37 °C for 30 525 on September 26, 2018 by guest http://jvi.asm.org/ Downloaded from minutes, spike-expressing cells were centrifuged, resuspended in fresh neutral pH 526 medium, and then overlaid onto receptor-expressing HEK293T cells at a ratio of 1:2. 527
When cell-cell fusion occurred, the expression of the luciferase gene would be activated 528 through binding of the GAL4-NF-kappaB fusion protein to GAL4 binding sites at the 529 promoter of the luciferase gene. After incubation for 24 hours, the cells were lysed, the 530 aliquots of cell lysates were transferred to an Optiplate-96 plate (PerkinElmer Life 531 Sciences), and then luciferase substrate (Promega) was added. Relative luciferase units 532
were measured using EnSpire plate reader (PerkinElmer Life Sciences). 533
Cleavage of coronavirus spikes using purified lysosomal extracts 534
HEK293T cells were transfected with pcDNA3.1(+) plasmid encoding MERS-535
CoV spike or HKU4 spike. 48 hours after transfection, the cells were harvested and 536
washed by PBS buffer. The cells were then treated with 50 µg/ml purified lysosomal 537 extracts at pH 5.6 for 30 minutes or 100 µg/ml purified lysosomal extracts at pH 5.6 for 538 different periods of time (i.e., 10, 30, 60 minutes). After treatment, the cells were lysed 539 and boiled for Western blotting analysis. The C9-tagged spikes were detected using an 540 anti-C9 tag monoclonal antibody (Santa Cruz Biotechnology). 
